Via its wholly-owned HIL-INVEST GmbH subsidiary, Bormioli Pharma SpA has confirmed its acquisition of a leading German pharmaceutical packaging business. R&G Beteiligungs GmbH employees approximately 270 people and operates plants in Schleusingen and Altenfeld, offering glass and plastic packaging. Last year, R&G registered a turnover of €25.6 million and an EBITDA equal to €4.1 million, representing a 16% margin.

Via this acquisition, Bormioli Pharma reinforces its presence in northern Europe, expanding its current product range with complementary products and strengthening its manufacturing footprint and industrial competences. Closing of the transaction is planned for the fourth quarter of 2019 and is subject to the obtainment of merger clearance by German authorities.